Abstract
Objective: Daily consumption of supplements containing 400 μg of folic acid in the periconception period may reduce the risk of neural tube defects (NTDs) by as much as 70%. However, despite explicit recommendations, folic acid consumption among women likely to become pregnant remains low. The objectives of this study were: to evaluate women’s knowledge and beliefs with regard to folic acid; to estimate the frequency of vitamin supplement consumption; and to identify its determinants during the periconception period.
Methods: In 1999–2000, a questionnaire was completed by 1,240 pregnant women in 10 Quebec hospitals.
Results: Seventy percent of the respondents were aware of the preventive role of folic acid but only 25% had taken the recommended dose of supplements during the periconception period. Supplement consumption is associated with the pregnancy planning intensity score (OR: 1.06; 95% CI: 1.02–1.11), knowledge score (OR: 1.11; 95% CI: 1.07–1.16) and belief in the usefulness of supplements (OR: 1.56; 95% CI: 1.02–2.39).
Conclusion: These results indicate that further efforts are needed to inform the population and promote the optimal use of folic acid supplements.
Résumé
Objectifs: La consommation journalière de suppléments contenant 400μg d’acide folique en période périconceptionnelle peut diminuer jusqu’à 70 % le risque d’anomalies de fermeture du tube neural (AFTN). Malgré des recommandations explicites, le niveau de consommation chez les femmes susceptibles de devenir enceintes demeure faible. Les objectifs de cette étude étaient d’évaluer les connaissances et les croyances des femmes en regard de l’acide folique ainsi que d’estimer leur fréquence de consommation de suppléments vitaminiques puis d’identifier les déterminants de cette consommation durant la période périconceptionnelle.
Méthode: En 1999–2000, lors d’une enquête, nous avons interrogé 1 240 femmes enceintes dans 10 hôpitaux du Québec.
Résultats: Soixante-dix pourcent des participantes connaissaient le rôle préventif de l’acide folique, mais seulement 25 % avaient pris des suppléments, à la dose recommandée, durant la période périconceptionnelle. La consommation de suppléments est associée au score d’intensité de la planification de la grossesse (OR: 1,06; 95 % IC: 1,02 à 1,11), au score de connaissances (OR: 1,11; 95 % IC: 1,07 à 1,16) et à la croyance en l’utilité des suppléments (OR: 1,56; 95% IC: 1,02 à 2,39).
Conclusion: Ces résultats indiquent que des efforts sont encore nécessaires pour informer la population et promouvoir l’utilisation optimale des suppléments d’acide folique.
Footnotes
Acknowledgements: This study was funded by Kellogg Canada Inc. Pascale Morin has a scholarship from the Danone Institute of Canada.
We thank Mrs. Louise Gravel-Roy and Geneviève Anctil for collecting the data. We also thank the employees from the participating hospitals: Centre hospitalier Angrignon, Centre hospitalier Anna-Laberge, Centre hospitalier d’Asbestos, Centre hospitalier Beauce-Etchemin, Centre hospitalier Notre-Dame–du-Lac, Centre hospitalier Pierre-Boucher, Centre hospitalier universitaire de Montréal, Centre universitaire de santé de l’Estrie, Hôpital La Pocatière et Hôtel-Dieu de Lévis.
References
- 1.Chambers K, Popkin J, Arnold W, Irwin B, Hall JG. Neural tube defects in British Columbia? Lancet. 1994;343(8895):489–90. doi: 10.1016/S0140-6736(94)92743-X. [DOI] [PubMed] [Google Scholar]
- 2.De Wals P, Trochet C, Pinsonneault L. Prevalence of neural tube defects in the province of Quebec, 1992. Can J Public Health. 1997;90(4):237–39. doi: 10.1007/BF03404123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Crane JMG, Sun C, Hutchens D, Crowley M. The epidemiology of neural tube defects in Newfoundland and Labrador. J Soc Obstet Gynecol Can. 2001;23:510–14. [Google Scholar]
- 4.Moore KL. L’être humain en développement. Embryologie orientée vers la clinique. Toronto: N.B. Saunders Company; 1974. [Google Scholar]
- 5.Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural tube defects. Medical Progress. 1999;341(20):1509–19. doi: 10.1056/NEJM199911113412006. [DOI] [PubMed] [Google Scholar]
- 6.McCourt C. Primary prevention of neural tube defects (issued by the HPB) CMAJ. 1993;148(9):1451. [PMC free article] [PubMed] [Google Scholar]
- 7.SOGC Genetics Committee. Folic acid for the prevention of neural tube defects. Pediatrics. 1993;92(3):493–94. [PubMed] [Google Scholar]
- 8.Canadian Task Force. Periodic Health Examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. CMAJ. 1994;151(2):159–66. [PMC free article] [PubMed] [Google Scholar]
- 9.Lewis CJ, Crane NT, Wilson DB, Yetley EA. Estimated folate intakes: Data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr. 1999;70:198–207. doi: 10.1093/ajcn.70.2.198. [DOI] [PubMed] [Google Scholar]
- 10.Raats M, Thorpe L, Hurren C, Elliott K. Changing Preconceptions. London: Health Education Authority; 1998. [Google Scholar]
- 11.Morin P, St-Cyr-Tribble D, De Wals P, Payette H. Concept analysis of pregnancy planning drawn from women of childbearing age. Health Promotion Practice. 2001;2(3):212–21. doi: 10.1177/152483990100200305. [DOI] [Google Scholar]
- 12.Miller WB. Personality traits and developmental experiences as antecedents of childbearing motivation? Demography. 1992;29(2):265–85. doi: 10.2307/2061731. [DOI] [PubMed] [Google Scholar]
- 13.Morin P, Payette H, Moos MK, St-Cyr-Tribble D, Niyonsenga T, De Wals P. Pediatric and Perinatal Epidemiology. 2002. Measuring the intensity of pregnancy planning. [DOI] [PubMed] [Google Scholar]
- 14.Pender NJ. Health Promotion in Nursing Practice. Third. Stanford, Connecticut: Appleton and Lange; 1996. [Google Scholar]
- 15.Bonin M, Bretzlaff J, Therrien S, Rowe B. Knowledge of periconceptional folic acid for the prevention of neural tube defects. The missing links. Arch Fam Med. 1998;7:438–42. doi: 10.1001/archfami.7.5.438. [DOI] [PubMed] [Google Scholar]
- 16.de Jong-van den B L, de Walle HEK, van der Pal-de Bruin KM, Buitendijk SE, Cornel MC. Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995. Eur Clin Pharmacol. 1998;54:329–31. doi: 10.1007/s002280050468. [DOI] [PubMed] [Google Scholar]
- 17.McDonnell R, Johnson Z, Doyle A, Sayers G. Folic acid knowledge and use among expectant mothers in 1997: A comparison with 1996? Ir Med J. 1999;92(3):296–301. [PubMed] [Google Scholar]
- 18.Goldstein H. Multilevel Statistical Models. Second 1995. [Google Scholar]
- 19.Rothman KJ, Greenland S. Modern Epidemiology. Second. Philadelphia, PA: Lippincott–Raven Publishers; 1998. [Google Scholar]
- 20.Hennekens CH, Buring JE. Epidemiology in Medicine. Toronto: Little, Brown and Company; 1987. [Google Scholar]
- 21.Green LL, Richard L, Potvin L. Ecological foundations of health promotion. Am J Health Prom. 1996;10(4):270–81. doi: 10.4278/0890-1171-10.4.270. [DOI] [PubMed] [Google Scholar]
- 22.Ruben BD. Communication and Human Behavior. New York: Macmillan Publishing Company; 1984. [Google Scholar]
